Indivior ( (INDV) ) just unveiled an update.
Indivior PLC announced the successful passage of all resolutions at its Annual General Meeting (AGM) held in London. The resolutions included the approval of the Directors’ Remuneration Report and Policy, election and re-election of board members, and authorization of various corporate actions. The results reflect strong shareholder support and are expected to positively impact the company’s governance and strategic initiatives.
More about Indivior
Indivior is a global pharmaceutical company focused on developing medicines to treat opioid use disorder (OUD). With a vision to provide evidence-based treatment for OUD worldwide, Indivior aims to transform OUD from a global crisis to a recognized chronic disease. Headquartered in Richmond, VA, the company employs over 1,000 people globally and offers its products in over 30 countries.
Average Trading Volume: 380,823
Technical Sentiment Signal: Sell
Current Market Cap: £1.09B
See more insights into INDV stock on TipRanks’ Stock Analysis page.